Fig. 5.
Percentages of participants who reported at least one of the following well-known systemic adverse events following immunization (AEFIs) stratified by a history of COVID-19 prior to vaccination: arthralgia, myalgia, nausea, pyrexia, headache, malaise, chills, fatigue, and fever (body temperature 38 °C or higher)
